Cargando…

Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes

OBJECTIVE: Immune suppression during critical illness predisposes to serious infections. We sought to determine the mechanisms regulating tolerance and cross-tolerance to common pro-inflammatory danger signals in a model that recapitulates the intact in vivo immune response. MATERIALS AND METHODS: F...

Descripción completa

Detalles Bibliográficos
Autores principales: Julian, Mark W., Strange, Heather R., Ballinger, Megan N., Hotchkiss, Richard S., Papenfuss, Tracey L., Crouser, Elliott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517781/
https://www.ncbi.nlm.nih.gov/pubmed/26218271
http://dx.doi.org/10.1371/journal.pone.0132921
_version_ 1782383239281770496
author Julian, Mark W.
Strange, Heather R.
Ballinger, Megan N.
Hotchkiss, Richard S.
Papenfuss, Tracey L.
Crouser, Elliott D.
author_facet Julian, Mark W.
Strange, Heather R.
Ballinger, Megan N.
Hotchkiss, Richard S.
Papenfuss, Tracey L.
Crouser, Elliott D.
author_sort Julian, Mark W.
collection PubMed
description OBJECTIVE: Immune suppression during critical illness predisposes to serious infections. We sought to determine the mechanisms regulating tolerance and cross-tolerance to common pro-inflammatory danger signals in a model that recapitulates the intact in vivo immune response. MATERIALS AND METHODS: Flt3-expanded splenocytes obtained from wild-type or matching IRAK-M knockout (IRAK-M-/-), C57BL/6, male mice (8–10 weeks old) were treated repeatedly or alternately with either LPS or CpGA DNA, agonists of Toll-like receptor (TLR)-4 and -9, respectively, over successive 24-hour periods. Supernatants were collected following each 24-hour period with cytokine release (ELISA) and splenocyte IRAK-M expression (Western blot) determined. Tolerance and cross-tolerance were assessed in the absence or presence of programmed death receptor (PD)-1 blocking antibody or IL-7 pre-treatment. MAIN RESULTS: Splenocytes notably exhibited both tolerance and cross-tolerance to subsequent treatments with either LPS or CpGA DNA. The character of tolerance and cross-tolerance in this model was distinct following initial LPS or CpGA treatment in that TNFα and IFNγ release (not IL-10) were suppressed following LPS; whereas, initial CpGA treatment suppressed TNFα, IFNγ and IL-10 release in response to subsequent stimulation (LPS or CpGA). Tolerance and cross-tolerance were unrelated to IL-10 release or PD-1 but were attenuated in IRAK-M-/- splenocytes. IL-7 significantly suppressed IRAK-M expression and restored TNFα and IFNγ production without influencing IL-10 release. CONCLUSIONS: In summary, acute immune tolerance and cross-tolerance in response to LPS or CpGA were distinct in that LPS selectively suppressed pro-inflammatory cytokine responses; whereas, CpGA suppressed both pro- and anti-inflammatory responses. The induction of tolerance and cross-tolerance in response to common danger signals was mechanistically unrelated to IL-10 or PD-1 but was directly influenced by IRAK-M expression. IL-7 reduced IRAK-M expression and attenuated immune tolerance induced by either LPS or CpGA, and thus may be useful for reversal of immune tolerance in the setting of critical illness.
format Online
Article
Text
id pubmed-4517781
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45177812015-07-31 Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes Julian, Mark W. Strange, Heather R. Ballinger, Megan N. Hotchkiss, Richard S. Papenfuss, Tracey L. Crouser, Elliott D. PLoS One Research Article OBJECTIVE: Immune suppression during critical illness predisposes to serious infections. We sought to determine the mechanisms regulating tolerance and cross-tolerance to common pro-inflammatory danger signals in a model that recapitulates the intact in vivo immune response. MATERIALS AND METHODS: Flt3-expanded splenocytes obtained from wild-type or matching IRAK-M knockout (IRAK-M-/-), C57BL/6, male mice (8–10 weeks old) were treated repeatedly or alternately with either LPS or CpGA DNA, agonists of Toll-like receptor (TLR)-4 and -9, respectively, over successive 24-hour periods. Supernatants were collected following each 24-hour period with cytokine release (ELISA) and splenocyte IRAK-M expression (Western blot) determined. Tolerance and cross-tolerance were assessed in the absence or presence of programmed death receptor (PD)-1 blocking antibody or IL-7 pre-treatment. MAIN RESULTS: Splenocytes notably exhibited both tolerance and cross-tolerance to subsequent treatments with either LPS or CpGA DNA. The character of tolerance and cross-tolerance in this model was distinct following initial LPS or CpGA treatment in that TNFα and IFNγ release (not IL-10) were suppressed following LPS; whereas, initial CpGA treatment suppressed TNFα, IFNγ and IL-10 release in response to subsequent stimulation (LPS or CpGA). Tolerance and cross-tolerance were unrelated to IL-10 release or PD-1 but were attenuated in IRAK-M-/- splenocytes. IL-7 significantly suppressed IRAK-M expression and restored TNFα and IFNγ production without influencing IL-10 release. CONCLUSIONS: In summary, acute immune tolerance and cross-tolerance in response to LPS or CpGA were distinct in that LPS selectively suppressed pro-inflammatory cytokine responses; whereas, CpGA suppressed both pro- and anti-inflammatory responses. The induction of tolerance and cross-tolerance in response to common danger signals was mechanistically unrelated to IL-10 or PD-1 but was directly influenced by IRAK-M expression. IL-7 reduced IRAK-M expression and attenuated immune tolerance induced by either LPS or CpGA, and thus may be useful for reversal of immune tolerance in the setting of critical illness. Public Library of Science 2015-07-28 /pmc/articles/PMC4517781/ /pubmed/26218271 http://dx.doi.org/10.1371/journal.pone.0132921 Text en © 2015 Julian et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Julian, Mark W.
Strange, Heather R.
Ballinger, Megan N.
Hotchkiss, Richard S.
Papenfuss, Tracey L.
Crouser, Elliott D.
Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
title Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
title_full Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
title_fullStr Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
title_full_unstemmed Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
title_short Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes
title_sort tolerance and cross-tolerance following toll-like receptor (tlr)-4 and -9 activation are mediated by irak-m and modulated by il-7 in murine splenocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517781/
https://www.ncbi.nlm.nih.gov/pubmed/26218271
http://dx.doi.org/10.1371/journal.pone.0132921
work_keys_str_mv AT julianmarkw toleranceandcrosstolerancefollowingtolllikereceptortlr4and9activationaremediatedbyirakmandmodulatedbyil7inmurinesplenocytes
AT strangeheatherr toleranceandcrosstolerancefollowingtolllikereceptortlr4and9activationaremediatedbyirakmandmodulatedbyil7inmurinesplenocytes
AT ballingermegann toleranceandcrosstolerancefollowingtolllikereceptortlr4and9activationaremediatedbyirakmandmodulatedbyil7inmurinesplenocytes
AT hotchkissrichards toleranceandcrosstolerancefollowingtolllikereceptortlr4and9activationaremediatedbyirakmandmodulatedbyil7inmurinesplenocytes
AT papenfusstraceyl toleranceandcrosstolerancefollowingtolllikereceptortlr4and9activationaremediatedbyirakmandmodulatedbyil7inmurinesplenocytes
AT crouserelliottd toleranceandcrosstolerancefollowingtolllikereceptortlr4and9activationaremediatedbyirakmandmodulatedbyil7inmurinesplenocytes